NorthStar Medical RDSTPS
NorthStar Medical RDSTPS is a leading innovator in the development of radiopharmaceutical therapy, specializing in the production of Actinium-225 and Copper-67. Their non-reactor based production processes are environmentally preferred and allow for reliable, scalable, commercial quantities, advancing the availability of radiopharmaceuticals for the treatment of cancer and other serious diseases.
With a mission to provide global access to game-changing radiopharmaceuticals, NorthStar combines cutting-edge technology, state-of-the-art facilities, and a team of experts all in one campus. Their patient-focused Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO CMO) addresses the critical need for advanced technologies in the field, offering solutions that are at the forefront of medical advancements.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.



